Robert Walton

Robert Walton is a Cochrane UK Senior Fellow in General Practice. Robert qualified in medicine in London in 1983, having taken an intercalated degree in human pharmacology and immunology. He trained at St Georges Hospital, London and became a member of the Royal College of Physicians in 1986. His work applying computerised decision support to prescribing drugs in the Department of Public Health and Primary care in Oxford led to a doctoral thesis in 1998. Robert was elected a Fellow of the Royal College of General Practitioners in 1999 and the Royal College of Physicians in 2001. He became a Senior Investigator in the National Institute for Health Research (NIHR) in 2016. Robert is Clinical Professor of Primary Medical Care at Queen Mary and was joint lead of the NIHR Research Design Service east London team. His research interests are in primary care, genetics, clinical trials and personalised medicine. Robert led a five-year NIHR funded programme developing a novel training intervention to promote smoking cessation in pharmacies in east London which included a substantive Cochrane review and meta analysis on behaviour change interventions in community pharmacies and a large scale cluster-randomised clinical trial. His research team is also developing a smartphone game to promote smoking cessation and researching a personalised/stratified medicine approach to tobacco dependence using computerised decision support. He sat on the NIHR Programme Grants for Applied Research sub panel A and worked as an evaluator for the European Union Horizon 2020 programmes Global Alliance for Chronic Diseases and New Therapies for Rare Diseases and as a monitor for EU projects. Robert contributes to UK national guidance, and has served on the National Institute for Health and Care Excellence (NICE) Outcome Indicator and Technology Appraisals Committees.